Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.41M Buy
+52,534
New +$3.08M 0.48% 90
2022
Q1
Sell
-22,838
Closed -$1.34M 281
2021
Q4
$1.34M Sell
22,838
-28,552
-56% -$1.73M 0.22% 225
2021
Q3
$3.12M Buy
51,390
+23,258
+83% +$1.36M 0.53% 44
2021
Q2
$1.69M Buy
+28,132
New +$1.41M 0.26% 176
2020
Q3
Sell
-54,558
Closed -$2.47M 276
2020
Q2
$2.47M Buy
+54,558
New +$2.79M 0.55% 49
2019
Q3
Sell
-18,326
Closed -$861K 237
2019
Q2
$861K Sell
18,326
-10,529
-36% -$445K 0.21% 206
2019
Q1
$1.01M Sell
28,855
-31,880
-52% -$1.25M 0.25% 186
2018
Q4
$2.27M Buy
+60,735
New +$2.37M 0.62% 36

Other funds holding ATEX

EAM Investors's ATEX Position: Q2 2026 in Review

EAM Investors opened a new position in Anterix (ATEX) in Q2 2026: 52,534 shares worth $5.41M. The stake represents 0.48% of the portfolio and ranks #90 among its holdings. This is a return to the name: EAM Investors previously reported a position in ATEX as recently as Q4 2021.

EAM Investors first reported a position in ATEX in Q4 2018 and has held it in 8 quarters since. 172 funds tracked by Wall St. Rank hold ATEX as of Q2 2026.

  • EAM Investors held 52,534 shares of Anterix worth $5.41M as of Q2 2026.
  • Anterix was a new EAM Investors position in Q2 2026.
  • Anterix made up 0.48% of EAM Investors's portfolio in Q2 2026, its #90 holding.
  • EAM Investors first reported a position in Anterix in Q4 2018 and has held it in 8 quarters since.
  • 172 funds tracked by Wall St. Rank held Anterix as of Q2 2026.

Based on EAM Investors's 13F filing for Q2 2026, filed 13 Aug 2026.